Basic Information
Elegen is a developer of microfluidic technology aimed at disrupting synthetic biology. The company leverages rapid advancements in whole-genome engineering and DNA synthesizers to accelerate biomedical progress, enabling the healthcare industry to advance DNA sequence testing.
Elegen Corporation
California,United States of America
less than 15 people
January 01, 2017
info@elegenbio.com

